These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 8174842

  • 1. Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study.
    Diabetologia; 1994 Mar; 37(3):278-85. PubMed ID: 8174842
    [Abstract] [Full Text] [Related]

  • 2. [Insulin-dependent diabetes mellitus:"EURODIAB IDDM Complications Study"--results from the Vienna center].
    Abrahamian H, Hörnlein B, Gurdet C, Willinger C, Zaruba E, Irsigler K.
    Wien Klin Wochenschr; 1994 Mar; 106(5):136-40. PubMed ID: 8171869
    [Abstract] [Full Text] [Related]

  • 3. Relation of fibre intake to HbA1c and the prevalence of severe ketoacidosis and severe hypoglycaemia. EURODIAB IDDM Complications Study Group.
    Buyken AE, Toeller M, Heitkamp G, Vitelli F, Stehle P, Scherbaum WA, Fuller JH.
    Diabetologia; 1998 Aug; 41(8):882-90. PubMed ID: 9726589
    [Abstract] [Full Text] [Related]

  • 4. Incidences of Severe Hypoglycemia and Diabetic Ketoacidosis and Prevalence of Microvascular Complications Stratified by Age and Glycemic Control in U.S. Adult Patients With Type 1 Diabetes: A Real-World Study.
    Pettus JH, Zhou FL, Shepherd L, Preblick R, Hunt PR, Paranjape S, Miller KM, Edelman SV.
    Diabetes Care; 2019 Dec; 42(12):2220-2227. PubMed ID: 31548241
    [Abstract] [Full Text] [Related]

  • 5. The relationship between smoking and microvascular complications in the EURODIAB IDDM Complications Study.
    Chaturvedi N, Stephenson JM, Fuller JH.
    Diabetes Care; 1995 Jun; 18(6):785-92. PubMed ID: 7555504
    [Abstract] [Full Text] [Related]

  • 6. Fibrinogen and von Willebrand factor in IDDM: relationships to lipid vascular risk factors, blood pressure, glycaemic control and urinary albumin excretion rate: the EURODIAB IDDM Complications Study.
    Greaves M, Malia RG, Goodfellow K, Mattock M, Stevens LK, Stephenson JM, Fuller JH.
    Diabetologia; 1997 Jun; 40(6):698-705. PubMed ID: 9222650
    [Abstract] [Full Text] [Related]

  • 7. Autonomic neuropathy is associated with increased cardiovascular risk factors: the EURODIAB IDDM Complications Study.
    Kempler P, Tesfaye S, Chaturvedi N, Stevens LK, Webb DJ, Eaton S, Kerényi Z, Tamás G, Ward JD, Fuller JH, EURODIAB IDDM Complications Study Group.
    Diabet Med; 2002 Nov; 19(11):900-9. PubMed ID: 12421426
    [Abstract] [Full Text] [Related]

  • 8. Different risk factors of microangiopathy in patients with type I diabetes mellitus of short versus long duration. The EURODIAB IDDM Complications Study.
    Karamanos B, Porta M, Songini M, Metelko Z, Kerenyi Z, Tamas G, Rottiers R, Stevens LK, Fuller JH.
    Diabetologia; 2000 Mar; 43(3):348-55. PubMed ID: 10768096
    [Abstract] [Full Text] [Related]

  • 9. The prevalence and severity of microvascular complications in pancreatic diabetes and IDDM.
    Levitt NS, Adams G, Salmon J, Marks IN, Musson G, Swanepoel C, Levy M, Byrne MJ.
    Diabetes Care; 1995 Jul; 18(7):971-4. PubMed ID: 7555558
    [Abstract] [Full Text] [Related]

  • 10. Retinopathy and vision loss in insulin-dependent diabetes in Europe. The EURODIAB IDDM Complications Study.
    Sjølie AK, Stephenson J, Aldington S, Kohner E, Janka H, Stevens L, Fuller J.
    Ophthalmology; 1997 Feb; 104(2):252-60. PubMed ID: 9052629
    [Abstract] [Full Text] [Related]

  • 11. Metabolic control and prevalence of microvascular complications in young Danish patients with Type 1 diabetes mellitus. Danish Study Group of Diabetes in Childhood.
    Olsen BS, Johannesen J, Sjølie AK, Borch-Johnsen K, Hougarrdss P, Thorsteinsson B, Prammingss S, Marinelli K, Mortensen HB.
    Diabet Med; 1999 Jan; 16(1):79-85. PubMed ID: 10229298
    [Abstract] [Full Text] [Related]

  • 12. Cardiovascular disease in insulin dependent diabetes mellitus: similar rates but different risk factors in the US compared with Europe.
    Orchard TJ, Stevens LK, Forrest KY, Fuller JH.
    Int J Epidemiol; 1998 Dec; 27(6):976-83. PubMed ID: 10024191
    [Abstract] [Full Text] [Related]

  • 13. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study.
    Tesfaye S, Stevens LK, Stephenson JM, Fuller JH, Plater M, Ionescu-Tirgoviste C, Nuber A, Pozza G, Ward JD.
    Diabetologia; 1996 Nov; 39(11):1377-84. PubMed ID: 8933008
    [Abstract] [Full Text] [Related]

  • 14. Is autonomic neuropathy a risk factor for severe hypoglycaemia? The EURODIAB IDDM Complications Study.
    Stephenson JM, Kempler P, Perin PC, Fuller JH.
    Diabetologia; 1996 Nov; 39(11):1372-6. PubMed ID: 8933007
    [Abstract] [Full Text] [Related]

  • 15. Glycaemic control and microvascular complications in a large cohort of Italian Type 1 diabetic out-patients.
    Lepore G, Bruttomesso D, Nosari I, Tiengo A, Trevisan R.
    Diabetes Nutr Metab; 2002 Aug; 15(4):232-9. PubMed ID: 12416660
    [Abstract] [Full Text] [Related]

  • 16. The relevance of persistent C-peptide secretion in type 1 (insulin-dependent) diabetes mellitus to glycaemic control and diabetic complications.
    Winocour PH, Jeacock J, Kalsi P, Gordon C, Anderson DC.
    Diabetes Res Clin Pract; 1990 Apr; 9(1):23-35. PubMed ID: 2351037
    [Abstract] [Full Text] [Related]

  • 17. The prevalence of cutaneous manifestations in IDDM patients and their association with diabetes risk factors and microvascular complications.
    Yosipovitch G, Hodak E, Vardi P, Shraga I, Karp M, Sprecher E, David M.
    Diabetes Care; 1998 Apr; 21(4):506-9. PubMed ID: 9571332
    [Abstract] [Full Text] [Related]

  • 18. The relationship between socioeconomic status and diabetes control and complications in the EURODIAB IDDM Complications Study.
    Chaturvedi N, Stephenson JM, Fuller JH.
    Diabetes Care; 1996 May; 19(5):423-30. PubMed ID: 8732703
    [Abstract] [Full Text] [Related]

  • 19. Relationship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes: the EURODIAB Complications Study.
    Crook MA, Pickup JC, Lumb PJ, Giorgino F, Webb DJ, Fuller JH, EURODIAB IDDM Complications Study Group.
    Diabetes Care; 2001 Feb; 24(2):316-22. PubMed ID: 11213885
    [Abstract] [Full Text] [Related]

  • 20. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial.
    Diabetes; 1996 Oct; 45(10):1289-98. PubMed ID: 8826962
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.